Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Dysregulation of the ALS-associated gene TDP-43 leads to neuronal death and degeneration in mice
Lionel M. Igaz, … , John Q. Trojanowski, Virginia M.-Y. Lee
Lionel M. Igaz, … , John Q. Trojanowski, Virginia M.-Y. Lee
Published January 4, 2011
Citation Information: J Clin Invest. 2011;121(2):726-738. https://doi.org/10.1172/JCI44867.
View: Text | PDF
Research Article Neuroscience

Dysregulation of the ALS-associated gene TDP-43 leads to neuronal death and degeneration in mice

  • Text
  • PDF
Abstract

Amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD) are characterized by cytoplasmic protein aggregates in the brain and spinal cord that include TAR-DNA binding protein 43 (TDP-43). TDP-43 is normally localized in the nucleus with roles in the regulation of gene expression, and pathological cytoplasmic aggregates are associated with depletion of nuclear protein. Here, we generated transgenic mice expressing human TDP-43 with a defective nuclear localization signal in the forebrain (hTDP-43-ΔNLS), and compared them with mice expressing WT hTDP-43 (hTDP-43-WT) to determine the effects of mislocalized cytoplasmic TDP-43 on neuronal viability. Expression of either hTDP-43-ΔNLS or hTDP-43-WT led to neuron loss in selectively vulnerable forebrain regions, corticospinal tract degeneration, and motor spasticity recapitulating key aspects of FTLD and primary lateral sclerosis. Only rare cytoplasmic phosphorylated and ubiquitinated TDP-43 inclusions were seen in hTDP-43-ΔNLS mice, suggesting that cytoplasmic inclusions were not required to induce neuronal death. Instead, neurodegeneration in hTDP-43 and hTDP-43-ΔNLS–expressing neurons was accompanied by a dramatic downregulation of the endogenous mouse TDP-43. Moreover, mice expressing hTDP-43-ΔNLS exhibited profound changes in gene expression in cortical neurons. Our data suggest that perturbation of endogenous nuclear TDP-43 results in loss of normal TDP-43 function(s) and gene regulatory pathways, culminating in degeneration of selectively vulnerable affected neurons.

Authors

Lionel M. Igaz, Linda K. Kwong, Edward B. Lee, Alice Chen-Plotkin, Eric Swanson, Travis Unger, Joe Malunda, Yan Xu, Matthew J. Winton, John Q. Trojanowski, Virginia M.-Y. Lee

×

Figure 6

Downregulation of endogenous nuclear mTDP-43 in neurons overexpressing cytoplasmic or nuclear hTDP-43.

Options: View larger image (or click on image) Download as PowerPoint
Downregulation of endogenous nuclear mTDP-43 in neurons overexpressing c...
(A–I) hTDP-43 downregulates mTDP-43. IF for hTDP-43 (green) or mTDP-43 (red) in DG of tTA/TDP-WT12 (A–C) or tTA/TDP-ΔNLS4 (D–F) 1 month off Dox showed neurons expressing hTDP-43 with loss of mTDP-43 staining (insets: higher magnification). (G–I) IF for hTDP-43 (red) or mTDP-43 (green) of cortex from tTA/TDP-WT12 mice 1 month off Dox showed loss of mTDP-43 expression in neurons expressing hTDP-43 (arrows). (J) Intranuclear mTDP-43 aggregates. IHC of tTA/TDP-ΔNLS19 cortex for mTDP-43 showed rare intranuclear aggregates (insets: higher magnification of boxed regions). Note the absence of mTDP-43 in neurons with aggregates (*) compared with a cell with reduced (**) or normal (***) mTDP-43 expression. Scale bars: 200 μm (A–F); 20 μm (G–I); 50 μm (J). (K) Reduced mTDP-43 protein in tTA/TDP mice. Immunoblot for hTDP-43, mTDP-43, and h+mTDP-43 of cortical RIPA extracts from tTA/TDP-WT12 or tTA/TDP-ΔNLS4 at various times off Dox showed increased hTDP-43 and reduced mTDP-43 protein relative to nTg (–/–) and tetO-TDP monogenic (+/–) mice. GAPDH is a loading control. (L) Quantification of immunostained sections of DG from tTA/TDP-WT12, tTA/TDP-ΔNLS4 mice, and control nTg and monogenic (tTA only or tetO-TDP only) mice (n = 29). The percentage of neurons with inclusions (green, p409/410 stained sections), percentage of neurons with reduced mTDP-43 expression (red, anti-mTDP43 stained sections) and percentage of neuronal degeneration (blue, H&E sections as in Figures 2 and 3) are shown as mean ± SEM versus time off Dox (t = 0 represents control mice).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts